Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC-Reference-Cited by-同舟云学术

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC

Published:2022-12-01 Issue:23 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Sena Laura A.,Kumar Rajendra^ORCID,Sanin David E.^ORCID,Thompson Elizabeth A.^ORCID,Rosen D. Marc,Dalrymple Susan L.,Antony Lizamma,Yang Yuhan,Gomes-Alexandre Carolina,Hicks Jessica L.,Jones Tracy,Bowers Kiara A.^ORCID,Eskra Jillian N.^ORCID,Meyers Jennifer,Gupta Anuj,Skaist Alyza,Yegnasubramanian Srinivasan^ORCID,Luo Jun,Brennen W. Nathaniel^ORCID,Kachhap Sushant K.^ORCID,Antonarakis Emmanuel S.^ORCID,De Marzo Angelo M.^ORCID,Isaacs John T.,Markowski Mark C.,Denmeade Samuel R.

Funder

Department of Defense

Johns Hopkins University

Prostate Cancer Foundation

National Institute of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/162396/files/pdf

Reference38 articles.

1. Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP

2. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation;Kokontis;Cancer Res,1994

3. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.

4. Bipolar androgen therapy: The rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer

5. Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study;Schweizer;Sci Transl Med,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells;Nature Communications;2024-09-03

2. Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer;Nature Communications;2024-08-28

3. Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines;International Journal of Molecular Sciences;2024-08-07

4. Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting;The Prostate;2024-04-29

5. Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial;Nature Communications;2024-01-02